Development and Evaluation of Candesartan Sustained Release Matrix Tablets
This study was undertaken to formulate and evaluate sustained-release matrix tablets of candesartan using Carbopol 934P in combination with chitosan or sodium alginate as release-modifying polymers. Candesartan, an angiotensin II receptor type-1 antagonist, was selected because its reported shorter half-life and need f...